Not applicableLooking for participantsNCT07124000What this trial is testingDESTINY-PANTUMOUR04Who this might be right forAdenocarcinoma (NOS)Anal CancerBladder Cancer+24 more AstraZeneca 100
Testing effectiveness (Phase 2)UnknownNCT02562365What this trial is testingAdjuvant Chemotherapy of Three-step Regimen in Ovarian CancerWho this might be right forOvarian Cancer Xiaohua Wu MD 130
Early research (Phase 1)Study completedNCT01489371What this trial is testingEGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more Gynecologic Oncology Group 16
Early research (Phase 1)Study completedNCT01649336What this trial is testingMEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer Array Biopharma, now a wholly owned subsidiary of Pfizer 36
Early research (Phase 1)Ended earlyNCT05827614What this trial is testingStudy of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsWho this might be right forTriple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more Boundless Bio, Inc. 85
Early research (Phase 1)Study completedNCT02009449What this trial is testingPegilodecakin (LY3500518) in Participants With Advanced Solid TumorsWho this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company 353
Early research (Phase 1)Ended earlyNCT04244552What this trial is testingA Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesWho this might be right forBreast CancerColorectal CancerOvarian Cancer+13 more Atreca, Inc. 87
Testing effectiveness (Phase 2)Ended earlyNCT00084448What this trial is testingPaclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003944What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00445549What this trial is testingVandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms National Cancer Institute (NCI) 12
Not applicableStudy completedNCT06103214What this trial is testingThe Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological SurgeryWho this might be right forOvarian Neoplasm Epithelial Zhejiang Cancer Hospital 144
Testing effectiveness (Phase 2)Study completedNCT00390611What this trial is testingPaclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian CancerWho this might be right forOvarian Cancer SCRI Development Innovations, LLC 85
Early research (Phase 1)Study completedNCT01440998What this trial is testingDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more National Cancer Institute (NCI) 18
Not applicableEnded earlyNCT00017134What this trial is testingFenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased RiskWho this might be right forOvarian Cancer Gynecologic Oncology Group 71
Testing effectiveness (Phase 2)Study completedNCT00035100What this trial is testingEPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal CancerWho this might be right forOvarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms Novartis Pharmaceuticals 54
Early research (Phase 1)Looking for participantsNCT06293898What this trial is testingOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsWho this might be right forEndometrial CancerCervical CancerOvarian Cancer+7 more SystImmune Inc. 280
Not applicableStudy completedNCT00986206What this trial is testingLysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian CancerWho this might be right forbrca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer Women and Infants Hospital of Rhode Island 525
Very early researchStudy completedNCT02013492What this trial is testingPropranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forMale Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more William Carson 1
Testing effectiveness (Phase 2)Ended earlyNCT02669914What this trial is testingMEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsWho this might be right forNon-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more Washington University School of Medicine 4
Early research (Phase 1)Study completedNCT00045175What this trial is testingUCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer University Health Network, Toronto 33